GMP Services
Decision Science Training for Risk-Based Decision-Making in Life Sciences
Leverage the pioneering research of Valerie
Mulholland PhD and transform your PQS decision making.
Our on demand e-learning series, informed by regulatory expertise and real Quality Risk Management (QRM) will provide you with the expertise you need to succeed.
Introducing:
The Decision Science Series
Introducing: The Decision Science Series
Designed to support Quality Risk Management (QRM) effectiveness – this is your shortcut to superior, defensible Risk-Based Decisions in Life Science Quality.
The
Challenge
The Challenge
The Solution
The 3
Pillars of our Decision Science Series
The 3 Pillars of our Decision Science Series
Pioneering PhD Research
The Foundation: Leveraging Valerie Mulholland's groundbreaking decision science research to provide scientifically rigorous methodology. This work was used to inform the ICH(R1) revision process and is in the ICH training material.
Cross Industry Expertise
The Edge: Essential insights from leading decision scientists, risk & data scientists and organizational psychologists and applied to decision making in the life science context.
PQS/QMS Application
The Goal: A practical framework for decision making and critical thinking, built for the Pharmaceutical Quality System (PQS) or Life Science QMS, giving you the ability to make, defensibly compliant decisions.
Who Needs This Series?
Dr Valerie Mulholland
Providing Thought Leadership: Empowering Pharma and Biotech Professionals with Decision Science and Risk-Based Strategies for a Modern, Effective Quality System. Valerie's work, is referenced in the official ICHQ9(R1) training material
I'm Valerie Mulholland, CEO of
GMP Services, and I'll guide you through much of this series.
These courses bring together my PhD research on RBDM and
a lifetime of experience in the life sciences.
My
mission is to make Decision Science accessible and actionable and to help you build decisions you can defend with
confidence.
Mastering risk-based decision making is a critical,
career-defining skill.
This knowledge is your strategic advantage,
equipping you to navigate subjectivity, uncertainty and complexity with confidence.
Quality Risk Management
In 2005, regulators published Quality Risk Management (QRM) guidelines (ICH Q9),
giving the pharmaceutical sector a license to innovate responsibly,
adopting new technologies and improved processes through evidence-led
decisions.
Progress stalled when organisations defaulted to methods better suited to other purposes, mistook scores for thinking, and ignored
the science of decision-making.
ICH Q9(R1) (2023) re-centres QRM on
decision science, emphasising decision quality, right-sized formality,
bias control, and real-world effectiveness.
Indeed risk
science and decision making has become central to many of the
ICH guidelines.
With AI
accelerating change, there is now an urgent need to build
decision-science capability so that QRM operates
as a learning engine that reduces patient risk, improves flow and yield,
and enables confident adoption of new technology.
The service that GMP Services is known for!
Our expertise spans the entire organization, equipping leadership teams and operations personnel alike with the knowledge to excel. Every program is custom-designed to ensure your specific learning goals are met.
Working with a wide range of clients in the life sciences sector for over 25 years has given us a unique perspective on the industry. This perspective is a valuable asset to our Life Science clients. We provide expertise to clients in the following sectors. Pharmaceutical, Bio-pharmaceutical, Blood & Tissue, Medical Devices, API, Excipients, Service Providers, ATMP Manufacturing, Contract Operations, & Contract Laboratories.
